ACUMEN PHARMACEUTICALS INC

ABOS Stock Forecast & Price Prediction

A data-driven outlook for ABOS built from live market pricing, discounted cash flow fair value, valuation multiples and ZCoreAI's Z-Score mean-reversion model. No opinions — only what the numbers currently imply.

$0.23+6.53% todayUSD · live quote
★ ZCoreAI PREMIUM7 days free

Start Your 7-Day ABOS Premium Trial

Explore the complete ABOS setup with live Z-Score, Smart Money signals, multi-timeframe analysis and premium indicators.

✓Z-Score signals
✓Smart Money flow
✓All timeframes
✓Premium indicators
Start 7-Day Free Trial →

7-day free trial. No commitment during the trial.

ABOS Price Outlook

A cash-flow based forecast for ABOS is unavailable — the backend could not produce a verified DCF valuation from current public data.

ABOS Historical Price Context

Two years of weekly closes for ABOS, with 52-week extremes and realized performance.

52-week high
$3.60
52-week low
$0.19
1-year performance
-87.8%
2-year performance
-90.3%

ABOS is trading 1% of the way up its 52-week range.

ABOS Valuation & Fundamentals

The multiples and growth rates that drive the ABOS forecast model.

Market cap
—
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
—
Revenue growth
—
EPS growth
—
Net margin
—
Discount rate
9.0%
See the full ABOS DCF fair value breakdown →

ABOS Technical & Smart Money Context

Live Z-Score readings measure how far ABOS has stretched from its statistical regression mean on each timeframe. Extreme readings historically precede mean reversion.

1H
-0.52
Statistically neutral
4H
-1.68
Statistically neutral
1D
-3.32
Statistically undervalued

How the ABOS Forecast Is Built

The ABOS price prediction combines three independent layers. First, a two-stage discounted cash flow model projects free cash flow ten years forward at 7.0% growth, applies a 2.5% perpetual terminal growth rate, and discounts every cash flow back to today at 9.0%. Second, current valuation multiples are compared against the growth and margin profile the company is actually delivering. Third, a Z-Score regression model measures how far price has stretched from its statistical mean on the 1H, 4H and daily timeframes.

Fair value is a valuation anchor, not a timing tool. A stock can stay above or below model fair value for long stretches, which is why the Z-Score layer exists — it identifies when ABOS is statistically stretched enough that mean reversion becomes probable. Nothing on this page is investment advice.

ABOS Stock Forecast FAQ

What is the ABOS stock forecast?

ZCoreAI derives the ABOS forecast from a DCF fair value, current valuation multiples, and live Z-Score mean-reversion statistics. It is a model output based on today's data, not a guarantee of future prices.

How is the ABOS price prediction calculated?

Free cash flow is projected ten years forward, a Gordon-growth terminal value is capitalized, and both are discounted to present value. Net cash and debt are added to reach equity value, which is divided by shares outstanding to get a per-share number that is compared to the live ABOS price.

Is ABOS overvalued or undervalued right now?

The model cannot produce a reliable fair value for ABOS from currently available public data.

What does the ABOS Z-Score mean?

The Z-Score measures standard deviations from a regression mean. Below -3 signals an unusually stretched downside move, above +3 signals a stretched upside move, and readings in between are statistically neutral.

Can I trade ABOS signals live?

Yes. Open ABOS in the ZCoreAI terminal to see Smart Money structure, signal markers and fair-value overlays on the live chart, or review every recent alert on the signals page.

ABOS fair value

Full DCF intrinsic value breakdown for ABOS.

ABOS dividends

Payout history, yield and dividend growth for ABOS.

Live trading signals

Every recent Z-Score buy and sell alert across the market.

Research tools we use

  • TradingView

    Charts, screeners and technical analysis across global markets.

  • Seeking Alpha

    Investment research, analysis and earnings coverage.

  • Koyfin

    Financial data, screening and market research dashboards.

Some links on this page are affiliate links. We may earn a commission if you purchase through them, at no additional cost to you.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.